Last update July 31, 2018
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Γλυκοζίτες στεβιόλης, Στέβια is Stevioside in Greek.Is written in other languages:
Γλυκοζίτες στεβιόλης, Στέβια is also known as
Γλυκοζίτες στεβιόλης, Στέβια belongs to these groups or families:
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
From the leaves of the Stevia rebaudiana plant originating in Paraguay several glycosides are obtained (rebaudiosides A, B, C, D and E, stevioside and dulcoside) which are used as a substitute for sugar.
The different glycosides are metabolized to steviol (Purkayastha 2016, Wheeler 2008).
It is a non-caloric sweetener, around 300 times sweeter than sucrose (Vargas 2012).
It has been commonly used in South America for centuries and in Japan and China for decades. It is used in traditional medicine with no proven scientific data on its effect on hypertension or hyperglycemia (Ulbricht 2010).
Devoid of toxicity (Gens 2003) at the dose of one or two cups of infusion daily. Maximum intake of steviol: 4 mg per Kg of weight per day.
Steviol glycosides are not genotoxic or carcinogenic (Urban 2013).
Since the last update we have not found published data on its excretion in breastmilk.
Given its lack of toxicity at correct doses, moderate consumption would be compatible with breastfeeding.